UNSPSC 51283203: Josamycin

This classification denotes a macrolide antibiotic with the molecular formula C42H69NO15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HV13HFS217, chemically known as stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-o-(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-3-(dimethylamino)-beta-d-glucopyranoside 4-acetate 4-isovalerate but generally known as josamycin, which bears US NIH Compound Identifier 5282165.

UNSPSC 51283203 Josamycin is a Commodity code covering pharmaceutical products that state and local governments procure as part of emergency response, community health, and pharmacy benefit programs. However, the recent opportunities tagged under this code show limited direct procurement of josamycin itself; instead, they reflect a broader pattern of state and local buying in emergency pharmaceuticals, naloxone and drug deactivation systems, generic multi-source medications, and OTC products through multiple acquisition pathways including direct vendor solicitation, cooperative purchasing alliances, and pharmacy benefit management arrangements. The issuing bodies span county health departments, municipal fire rescue divisions, state health and human services commissions, and multistate cooperative purchasing organizations serving state and local facilities. Seminole County, Florida, the City of Tampa, the Texas Health and Human Services Commission, and the Minnesota Department of Administration (administering the multistate MMCAP alliance) have all posted opportunities in this space recently.

The geographic spread of recent activity includes Florida, Texas, Minnesota, and Oregon, with the multistate MMCAP cooperative potentially extending reach across additional jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year initial term; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies to the Fire Department Rescue Division under a $700,000 estimated contract with SLBE set-asides and a 5 percent bid discount; and the Minnesota Department of Administration's MMCAP RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers with contracts effective July 1, 2026. Texas HHS also issued an exploratory RFI (HHS0017013, posted April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional PBM and GPO channels.